Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

CorMedix Inc.

CRMD Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of CRMD by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
CRMD Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
CRMD Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
CRMD Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in CRMD holdings by institutional investors

Quarterly net insider trading by CRMD's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

  • $220,000 Jul 31, 2026 Issue: Health Issues
  • $380,000 Jul 02, 2026 Issue: Health Issues
  • $150,000 Feb 05, 2026 Issue: Health Issues
  • $150,000 Oct 20, 2025 Issue: Health Issues
  • $150,000 Jul 31, 2025 Issue: Health Issues
  • $200,000 Apr 21, 2025 Issue: Health Issues
  • $150,000 Jan 21, 2025 Issue: Health Issues
  • $150,000 Oct 21, 2024 Issue: Health Issues
  • $240,000 Jul 22, 2024 Issue: Health Issues
  • $50,000 Jul 18, 2024 Issue: Health Issues
  • $360,000 Jan 22, 2024 Issue: Health Issues
  • $230,000 Oct 20, 2023 Issue: Health Issues
  • $50,000 Jul 20, 2023 Issue: Health Issues
  • $30,000 Jul 14, 2023 Issue: Medicare/Medicaid
  • $10,000 Oct 17, 2018 Issue: Health Issues
  • $20,000 Apr 19, 2018 Issue: Health Issues
  • $30,000 Jan 19, 2018 Issue: Health Issues
  • $30,000 Oct 17, 2017 Issue: Health Issues
  • $30,000 Jul 19, 2017 Issue: Health Issues
  • $30,000 Apr 20, 2017 Issue: Health Issues
  • $30,000 Jan 23, 2017 Issue: Health Issues
  • $30,000 Oct 20, 2016 Issue: Health Issues
  • $30,000 Jul 20, 2016 Issue: Health Issues
  • $30,000 Apr 20, 2016 Issue: Health Issues
  • $30,000 Jan 20, 2016 Issue: Health Issues
  • $30,000 Oct 20, 2015 Issue: Health Issues

Former government officials who have lobbied for CRMD

15 former government officials from 9 congressional offices at 6 lobbying firms have lobbied for CRMD, most recently Jul 19, 2024.

  • Nicholas Uehlecke House Senior Advisor, Dept. of Health and Human Services; Professional Staff/Sr. Legislative Assistant, House Ways and Means Subcommittee Formerly Senior Advisor, Dept. of Health and Human Services; Professional Staff/Sr. Legis · TODD STRATEGY GROUP · Jul 19, 2024
  • John B. Shadegg
    Paul Edattel House Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg Formerly with John B. Shadegg · TODD STRATEGY GROUP · Jul 19, 2024
  • Bill Cassidy
    Jeff Lucas Senate Health Policy Advisor, Senator Bill Cassidy; Legislative Assistant/Sr. Legislative Assistant/Legislative Correspondent, Representative Larry Bucshon Formerly with Bill Cassidy · TODD STRATEGY GROUP · Jul 19, 2024
  • Daniel Todd Senate Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Admin. Ct. - Medicare & Medicaid Formerly Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Ad · TODD STRATEGY GROUP · Jul 19, 2024
  • Thom Tillis
    Ted Lehman Senate Chief of Staff, Senator Tillis; Senate Judiciary Committee-Counsel, then Chief Counsel for Nominations and Senior Counsel; Senate Judiciary Committee-Staff Assistant and Legislative Assistant Formerly with Thom Tillis · TODD STRATEGY GROUP · Jul 19, 2024
  • Michael C. Burgess
    Taylor Sexton House Advisor to the Assistant Secretary for Preparedness & Response, HHS; Advisor to the Assistant Secretary of Legislation, HHS; Health Care Policy Fellow, Representative Michael Burgess Formerly with Michael C. Burgess · TODD STRATEGY GROUP · Jul 19, 2024
  • Brett Guthrie
    Katherine Cotton House Staff Assistant, Legislative Correspondent, Legislative Assistant - U.S. Representative Brett Guthrie Formerly with Brett Guthrie · TODD STRATEGY GROUP · Jul 19, 2024
  • Brett Guthrie
    Eric Bergren House Chief of Staff, Rep. Brett Guthrie; Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director, Chief of Staff - Rep. Ron Lewis; Intern, Rep. Bill Baker Formerly with Brett Guthrie · TODD STRATEGY GROUP · Jul 19, 2024
See all 15 on the Revolving Door dashboard

CRMD Estimated quarterly lobbying spending

CRMD Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
CRMD Income Statement
CRMD Balance Sheet
CRMD Cash Flow
U.S. Patents

New CRMD patent grants

  • Patent Title: Antimicrobial compositions, including antimicrobial hydrogels, effective against mature biofilms May. 20, 2025
  • Patent Title: Taurultam, taurinamide and methylene glycol treatment for myc—expressing tumors in mammalian bodies Aug. 06, 2024
  • Patent Title: Methods and pharmaceutical compositions for treating candida auris in blood Jun. 25, 2024
  • Patent Title: Synthesis of taurolidine, purity profiles and polymorphs Aug. 29, 2023
  • Patent Title: Neuroblastoma treatment with taurolidine hydrolysis products Jan. 03, 2023
  • Patent Title: Antimicrobial wound closure materials, including antimicrobial sutures, and method for closing a wound using the same Dec. 31, 2019
  • Patent Title: Field sterilizer and vascular connector kit Nov. 19, 2019
Government Contracts

Estimated quarterly amount awarded to CRMD from public contracts

CRMD News

Recent insights relating to CRMD

CNBC Recommendations

Recent picks made for CRMD stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in CRMD

CRMD Analyst Ratings

CRMD Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
CRMD Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $CRMD stock a Buy, Sell, or Hold?

  • What is the price target for $CRMD stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

CRMD Top Shareholders
Shareholder
Shares Held
CRMD Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $CRMD stock?

  • Who owns the most shares of $CRMD stock?

  • What funds own $CRMD stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

CRMD Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view CRMD Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About CRMD

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

  • Address Parsippany, NJ
  • Market Cap 599.4 million
  • Employees 191
  • Industrial Classification Pharmaceutical Preparations

CorMedix Inc. (CRMD) Historical Stock Prices

CorMedix Inc. (CRMD) closed at $7.69 on September 23, 2026. Over the past year its adjusted close ranged from $6.25 to $12.73. Daily prices go back to January 2, 2014, 3,200 trading days in all.

  • 1 month-7.13%
  • 3 months-8.34%
  • Year to date-33.88%
  • 1 year-32.78%
  • 3 years+109.54%
  • 5 years+65.02%
  • Max+13.09%
See every congressional and insider trade on the CRMD price chart

Quiver Premium charts CRMD's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 23, 2026 8.03 8.19 7.62 7.69 7.69 812,571
Sep 22, 2026 7.83 7.83 7.69 7.78 7.78 788,926
Sep 21, 2026 7.72 7.82 7.62 7.77 7.77 505,842
Sep 18, 2026 7.65 7.79 7.62 7.72 7.72 1,806,488
Sep 17, 2026 7.86 7.92 7.70 7.79 7.79 684,745
Sep 16, 2026 7.78 7.87 7.72 7.82 7.82 664,712
Sep 15, 2026 7.90 7.90 7.71 7.76 7.76 718,708
Sep 14, 2026 7.83 7.95 7.75 7.89 7.89 920,272
Sep 11, 2026 8.04 8.06 7.82 7.83 7.83 820,993
Sep 10, 2026 8.11 8.12 7.92 7.96 7.96 857,257
Sep 9, 2026 8.18 8.33 8.08 8.13 8.13 928,241
Sep 8, 2026 8.28 8.37 8.11 8.18 8.18 1,101,106
Sep 4, 2026 8.45 8.61 8.31 8.43 8.43 792,913
Sep 3, 2026 8.69 8.74 8.43 8.47 8.47 707,673
Sep 2, 2026 8.40 8.62 8.33 8.61 8.61 1,102,064
Sep 1, 2026 8.25 8.49 8.18 8.38 8.38 880,480
Aug 31, 2026 8.26 8.29 8.06 8.26 8.26 980,535
Aug 28, 2026 8.28 8.39 8.19 8.30 8.30 780,215
Aug 27, 2026 8.49 8.49 8.28 8.31 8.31 707,586
Aug 26, 2026 8.60 8.61 8.37 8.39 8.39 865,512
Aug 25, 2026 8.35 8.57 8.28 8.56 8.56 1,235,615
Aug 24, 2026 8.28 8.49 8.18 8.28 8.28 1,012,332
Aug 21, 2026 8.29 8.41 8.15 8.20 8.20 1,496,715
Aug 20, 2026 8.49 8.54 8.19 8.23 8.23 1,006,384
Aug 19, 2026 8.30 8.53 8.11 8.52 8.52 1,467,119
Aug 18, 2026 7.71 8.27 7.71 8.17 8.17 2,033,422
Aug 17, 2026 7.55 8.11 7.48 7.67 7.67 2,173,712
Aug 14, 2026 8.05 8.20 7.46 7.54 7.54 2,701,417
Aug 13, 2026 8.39 8.98 7.76 8.14 8.14 6,069,943
Aug 12, 2026 7.30 7.31 7.10 7.10 7.10 1,353,419
Aug 11, 2026 7.60 7.62 7.25 7.30 7.30 1,182,274
Aug 10, 2026 7.40 7.55 7.31 7.53 7.53 842,650
Aug 7, 2026 7.58 7.58 7.39 7.44 7.44 740,966
Aug 6, 2026 7.43 7.52 7.38 7.51 7.51 702,374
Aug 5, 2026 7.52 7.57 7.37 7.41 7.41 615,544
Aug 4, 2026 7.60 7.66 7.48 7.52 7.52 651,739
Aug 3, 2026 7.60 7.63 7.40 7.55 7.55 856,106
Jul 31, 2026 7.49 7.55 7.30 7.53 7.53 637,870
Jul 30, 2026 7.28 7.58 7.23 7.49 7.49 1,182,763
Jul 29, 2026 7.36 7.43 7.13 7.19 7.19 1,362,491
Jul 28, 2026 7.60 7.69 7.27 7.35 7.35 1,251,835
Jul 27, 2026 8.00 8.12 7.58 7.60 7.60 1,183,744
Jul 24, 2026 8.07 8.09 7.83 7.87 7.87 625,290
Jul 23, 2026 7.85 8.07 7.76 8.05 8.05 698,511
Jul 22, 2026 8.18 8.20 7.86 7.94 7.94 860,115
Jul 21, 2026 7.82 8.21 7.82 8.19 8.19 1,038,432
Jul 20, 2026 8.48 8.53 7.69 7.78 7.78 1,156,381
Jul 17, 2026 8.14 8.53 8.14 8.42 8.42 694,737
Jul 16, 2026 8.39 8.50 8.25 8.29 8.29 874,704
Jul 15, 2026 8.26 8.43 8.11 8.42 8.42 648,439
Jul 14, 2026 8.29 8.43 8.22 8.27 8.27 806,842
Jul 13, 2026 8.28 8.41 8.22 8.32 8.32 886,189
Jul 10, 2026 8.68 8.72 8.22 8.40 8.40 808,448
Jul 9, 2026 8.86 8.93 8.67 8.67 8.67 811,522
Jul 8, 2026 8.91 8.98 8.76 8.83 8.83 824,494
Jul 7, 2026 8.73 8.95 8.61 8.87 8.87 841,645
Jul 6, 2026 8.73 8.89 8.54 8.79 8.79 1,180,873
Jul 2, 2026 8.55 8.84 8.42 8.75 8.75 1,043,904
Jul 1, 2026 7.99 8.53 7.98 8.47 8.47 1,277,023
Jun 30, 2026 7.65 7.86 7.58 7.85 7.85 1,359,905
Jun 29, 2026 7.72 7.95 7.50 7.64 7.64 1,283,598
Jun 26, 2026 7.72 7.96 7.59 7.85 7.85 4,576,864
Jun 25, 2026 8.53 8.53 7.62 7.72 7.72 3,042,329
Jun 24, 2026 8.69 8.82 8.39 8.39 8.39 1,382,568
Jun 23, 2026 8.75 8.96 8.60 8.60 8.60 1,272,538
Jun 22, 2026 8.70 9.06 8.70 8.82 8.82 1,957,827
Jun 18, 2026 8.84 8.85 8.65 8.67 8.67 2,521,886
Jun 17, 2026 8.66 8.81 8.63 8.67 8.67 1,189,005
Jun 16, 2026 8.60 8.70 8.46 8.66 8.66 847,801
Jun 15, 2026 8.91 8.91 8.49 8.59 8.59 1,412,783
Jun 12, 2026 8.95 9.01 8.72 8.74 8.74 969,813
Jun 11, 2026 8.80 9.09 8.73 8.96 8.96 1,237,932
Jun 10, 2026 8.65 8.98 8.61 8.77 8.77 1,317,079
Jun 9, 2026 8.61 8.83 8.46 8.65 8.65 1,412,758
Jun 8, 2026 8.45 8.58 8.36 8.54 8.54 1,773,860
Jun 5, 2026 8.59 8.68 8.33 8.36 8.36 906,183
Jun 4, 2026 8.28 8.74 8.15 8.54 8.54 1,446,830
Jun 3, 2026 8.19 8.27 8.09 8.23 8.23 835,955
Jun 2, 2026 8.40 8.41 8.10 8.17 8.17 964,191
Jun 1, 2026 8.40 8.54 8.34 8.45 8.45 1,196,534
May 29, 2026 8.41 8.47 8.26 8.44 8.44 1,041,519
May 28, 2026 8.43 8.55 8.36 8.42 8.42 1,287,664
May 27, 2026 8.29 8.54 8.25 8.46 8.46 1,088,878
May 26, 2026 8.07 8.29 8.02 8.27 8.27 1,313,577
May 22, 2026 8.06 8.14 7.96 7.98 7.98 826,229
May 21, 2026 7.89 8.07 7.77 8.06 8.06 1,386,610
May 20, 2026 7.90 8.04 7.64 7.93 7.93 1,418,725
May 19, 2026 7.91 8.03 7.76 7.82 7.82 1,737,278
May 18, 2026 7.60 7.99 7.52 7.91 7.91 2,004,543
May 15, 2026 7.95 8.21 7.50 7.55 7.55 2,835,692
May 14, 2026 8.54 8.94 7.86 7.93 7.93 4,321,451
May 13, 2026 7.53 7.65 7.43 7.50 7.50 1,127,583
May 12, 2026 7.65 7.65 7.43 7.51 7.51 1,190,624
May 11, 2026 7.90 8.09 7.63 7.66 7.66 1,112,420
May 8, 2026 8.03 8.15 7.82 7.92 7.92 858,922
May 7, 2026 8.05 8.13 7.85 7.92 7.92 893,174
May 6, 2026 7.85 8.11 7.81 8.05 8.05 1,164,884
May 5, 2026 7.90 7.92 7.67 7.73 7.73 850,281
May 4, 2026 7.75 8.04 7.62 7.90 7.90 1,100,568
May 1, 2026 7.65 7.84 7.61 7.79 7.79 735,949
Apr 30, 2026 7.54 7.66 7.51 7.59 7.59 636,483
Apr 29, 2026 7.58 7.63 7.43 7.48 7.48 1,002,626
Apr 28, 2026 7.89 7.98 7.54 7.57 7.57 1,222,628
Apr 27, 2026 7.53 7.91 7.48 7.82 7.82 1,689,470
Apr 24, 2026 7.31 7.43 7.27 7.42 7.42 656,966
Apr 23, 2026 7.49 7.54 7.30 7.33 7.33 755,147
Apr 22, 2026 7.49 7.64 7.42 7.49 7.49 882,639
Apr 21, 2026 7.62 7.62 7.36 7.38 7.38 798,920
Apr 20, 2026 7.32 7.71 7.27 7.58 7.58 1,043,110
Apr 17, 2026 7.27 7.44 7.05 7.39 7.39 1,263,955
Apr 16, 2026 7.26 7.34 7.12 7.13 7.13 868,598
Apr 15, 2026 7.41 7.43 7.14 7.23 7.23 1,079,583
Apr 14, 2026 7.35 7.48 7.29 7.30 7.30 1,164,629
Apr 13, 2026 7.21 7.37 7.17 7.32 7.32 906,736
Apr 10, 2026 7.40 7.41 7.20 7.24 7.24 636,767
Apr 9, 2026 7.23 7.38 7.20 7.36 7.36 723,307
Apr 8, 2026 7.42 7.42 7.15 7.23 7.23 883,094
Apr 7, 2026 7.06 7.20 6.99 7.17 7.17 897,536
Apr 6, 2026 7.08 7.15 7.02 7.08 7.08 825,759
Apr 2, 2026 6.89 7.07 6.82 7.05 7.05 1,671,218
Apr 1, 2026 6.89 7.05 6.80 7.02 7.02 1,168,894
Mar 31, 2026 6.61 6.89 6.60 6.79 6.79 1,237,302
Mar 30, 2026 6.72 6.98 6.56 6.57 6.57 1,265,626
Mar 27, 2026 6.78 6.98 6.63 6.71 6.71 1,513,117
Mar 26, 2026 6.57 6.76 6.50 6.70 6.70 1,153,869
Mar 25, 2026 6.58 6.71 6.52 6.61 6.61 918,122
Mar 24, 2026 6.38 6.48 6.31 6.46 6.46 1,273,330
Mar 23, 2026 6.33 6.50 6.28 6.42 6.42 1,428,605
Mar 20, 2026 6.21 6.33 6.16 6.25 6.25 2,013,044
Mar 19, 2026 6.37 6.48 6.25 6.30 6.30 1,257,258
Mar 18, 2026 6.40 6.43 6.21 6.37 6.37 1,348,289
Mar 17, 2026 6.57 6.62 6.43 6.46 6.46 1,353,972
Mar 16, 2026 6.50 6.60 6.45 6.54 6.54 1,200,434
Mar 13, 2026 6.40 6.49 6.22 6.45 6.45 1,899,270
Mar 12, 2026 6.59 6.62 6.30 6.40 6.40 1,420,103
Mar 11, 2026 6.73 6.83 6.51 6.69 6.69 1,395,801
Mar 10, 2026 6.62 6.86 6.55 6.72 6.72 1,821,426
Mar 9, 2026 6.28 6.59 6.14 6.56 6.56 2,720,813
Mar 6, 2026 6.31 6.46 6.12 6.46 6.46 2,566,023
Mar 5, 2026 6.35 6.55 6.13 6.30 6.30 4,220,879
Mar 4, 2026 6.97 7.20 6.92 7.12 7.12 1,311,784
Mar 3, 2026 6.92 7.12 6.80 6.91 6.91 1,581,236
Mar 2, 2026 6.97 7.22 6.80 7.21 7.21 1,242,119
Feb 27, 2026 7.20 7.26 7.04 7.13 7.13 1,395,873
Feb 26, 2026 7.32 7.44 7.21 7.35 7.35 1,004,355
Feb 25, 2026 7.13 7.33 7.07 7.31 7.31 681,190
Feb 24, 2026 7.01 7.13 6.95 7.07 7.07 969,846
Feb 23, 2026 6.96 7.12 6.89 7.01 7.01 1,169,910
Feb 20, 2026 7.07 7.22 6.95 7.03 7.03 2,059,192
Feb 19, 2026 7.17 7.21 7.06 7.08 7.08 1,212,549
Feb 18, 2026 7.21 7.32 7.08 7.17 7.17 1,173,263
Feb 17, 2026 7.36 7.45 7.15 7.21 7.21 1,426,556
Feb 13, 2026 7.38 7.74 7.33 7.34 7.34 1,782,326
Feb 12, 2026 7.49 7.52 7.29 7.36 7.36 1,303,923
Feb 11, 2026 7.77 7.78 7.34 7.43 7.43 2,741,409
Feb 10, 2026 7.57 7.85 7.51 7.69 7.69 1,912,711
Feb 9, 2026 7.66 7.72 7.56 7.58 7.58 1,337,544
Feb 6, 2026 7.47 7.72 7.40 7.69 7.69 1,574,161
Feb 5, 2026 7.77 7.92 7.33 7.35 7.35 1,821,901
Feb 4, 2026 8.22 8.27 7.73 7.84 7.84 2,183,725
Feb 3, 2026 8.23 8.34 8.05 8.12 8.12 1,583,618
Feb 2, 2026 8.09 8.53 8.04 8.17 8.17 3,485,198
Jan 30, 2026 8.09 8.15 7.66 7.76 7.76 2,356,760
Jan 29, 2026 7.75 8.14 7.75 8.02 8.02 2,850,317
Jan 28, 2026 7.77 7.92 7.71 7.75 7.75 1,909,091
Jan 27, 2026 7.76 7.89 7.58 7.75 7.75 2,646,201
Jan 26, 2026 7.27 7.78 7.18 7.76 7.76 2,929,556
Jan 23, 2026 7.36 7.52 7.14 7.27 7.27 2,515,169
Jan 22, 2026 7.35 7.59 7.28 7.44 7.44 2,720,335
Jan 21, 2026 6.88 7.34 6.82 7.33 7.33 2,807,333
Jan 20, 2026 6.56 6.89 6.55 6.88 6.88 2,335,246
Jan 16, 2026 6.95 7.08 6.77 6.78 6.78 2,889,627
Jan 15, 2026 7.09 7.21 6.90 7.01 7.01 3,309,063
Jan 14, 2026 7.05 7.44 7.04 7.09 7.09 3,497,725
Jan 13, 2026 7.15 7.31 7.05 7.06 7.06 2,763,683
Jan 12, 2026 7.58 7.59 7.01 7.15 7.15 5,288,141
Jan 9, 2026 7.61 8.17 7.60 7.63 7.63 8,341,375
Jan 8, 2026 8.73 9.41 7.22 7.51 7.51 23,664,063
Jan 7, 2026 11.33 11.58 10.94 11.17 11.17 2,476,002
Jan 6, 2026 12.29 12.29 11.19 11.26 11.26 4,114,009
Jan 5, 2026 12.19 12.23 11.70 12.19 12.19 2,262,980
Jan 2, 2026 11.81 12.29 11.74 12.16 12.16 2,157,120
Dec 31, 2025 12.40 12.45 11.62 11.63 11.63 3,602,304
Dec 30, 2025 12.74 13.02 12.46 12.48 12.48 2,285,184
Dec 29, 2025 12.50 12.82 12.36 12.73 12.73 2,173,429
Dec 26, 2025 12.20 12.61 12.07 12.53 12.53 1,952,258
Dec 24, 2025 12.09 12.24 12.00 12.19 12.19 957,669
Dec 23, 2025 12.35 12.35 11.78 11.98 11.98 1,713,713
Dec 22, 2025 12.02 12.51 11.83 12.39 12.39 1,775,423
Dec 19, 2025 11.86 12.07 11.75 12.02 12.02 3,686,267
Dec 18, 2025 11.57 12.05 11.52 11.92 11.92 2,753,450
Dec 17, 2025 11.44 11.64 11.31 11.45 11.45 2,273,803
Dec 16, 2025 11.31 11.60 11.29 11.44 11.44 2,143,432
Dec 15, 2025 11.52 11.54 11.04 11.33 11.33 3,239,565
Dec 12, 2025 11.91 11.91 11.49 11.49 11.49 3,554,836
Dec 11, 2025 11.45 11.81 11.36 11.74 11.74 4,109,590
Dec 10, 2025 11.45 11.54 10.90 11.47 11.47 3,587,356
Dec 9, 2025 11.28 12.10 11.09 11.62 11.62 5,826,322
Dec 8, 2025 10.76 11.31 10.65 11.26 11.26 2,983,979
Dec 5, 2025 10.63 10.78 10.38 10.56 10.56 1,610,866
Dec 4, 2025 10.33 10.76 10.27 10.64 10.64 2,462,675
Dec 3, 2025 9.84 10.36 9.75 10.32 10.32 2,153,247
Dec 2, 2025 9.91 10.10 9.68 9.78 9.78 2,458,152
Dec 1, 2025 9.69 9.85 9.56 9.79 9.79 1,918,726
Nov 28, 2025 9.65 9.88 9.56 9.81 9.81 988,157
Nov 26, 2025 9.44 9.67 9.30 9.65 9.65 2,183,636
Nov 25, 2025 9.72 9.75 9.20 9.40 9.40 3,214,494
Nov 24, 2025 9.72 10.00 9.70 9.82 9.82 3,108,740
Nov 21, 2025 9.53 9.80 9.45 9.68 9.68 2,526,173
Nov 20, 2025 10.14 10.24 9.54 9.72 9.72 3,075,292
Nov 19, 2025 10.09 10.40 9.88 10.03 10.03 2,138,887
Nov 18, 2025 9.98 10.34 9.93 10.07 10.07 2,007,934
Nov 17, 2025 11.17 11.19 9.81 9.98 9.98 5,591,748
Nov 14, 2025 10.83 11.62 10.77 11.24 11.24 3,082,651
Nov 13, 2025 11.42 11.97 11.15 11.21 11.21 5,982,080
Nov 12, 2025 11.74 12.89 10.75 11.42 11.42 9,364,489
Nov 11, 2025 11.04 11.28 10.90 11.19 11.19 2,390,426
Nov 10, 2025 10.94 11.23 10.86 11.08 11.08 2,948,572
Nov 7, 2025 10.59 10.85 10.51 10.76 10.76 1,812,105
Nov 6, 2025 11.25 11.27 10.68 10.78 10.78 2,112,009
Nov 5, 2025 11.36 11.54 11.12 11.16 11.16 1,907,906
Nov 4, 2025 11.19 11.68 11.06 11.42 11.42 3,228,496
Nov 3, 2025 11.22 11.55 10.87 11.54 11.54 2,813,249
Oct 31, 2025 11.82 11.90 10.95 11.13 11.13 2,177,244
Oct 30, 2025 11.38 11.90 11.36 11.62 11.62 2,225,019
Oct 29, 2025 11.16 11.70 10.96 11.31 11.31 3,302,339
Oct 28, 2025 11.65 11.84 11.08 11.14 11.14 2,615,663
Oct 27, 2025 11.30 11.32 10.92 11.05 11.05 1,568,713
Oct 24, 2025 11.34 11.57 11.07 11.17 11.17 1,841,804
Oct 23, 2025 11.30 11.41 10.97 11.31 11.31 1,516,839
Oct 22, 2025 11.61 11.72 11.02 11.20 11.20 2,279,659
Oct 21, 2025 12.25 12.45 11.56 11.65 11.65 3,267,152
Oct 20, 2025 11.78 12.56 11.22 12.16 12.16 8,135,067
Oct 17, 2025 10.00 10.21 9.87 10.18 10.18 1,945,039
Oct 16, 2025 10.65 10.76 10.04 10.08 10.08 2,291,641
Oct 15, 2025 10.57 10.94 10.57 10.61 10.61 1,696,721
Oct 14, 2025 10.50 10.72 10.40 10.54 10.54 1,503,653
Oct 13, 2025 10.81 10.87 10.38 10.58 10.58 1,895,473
Oct 10, 2025 10.98 11.06 10.55 10.73 10.73 1,943,935
Oct 9, 2025 11.30 11.31 10.92 11.00 11.00 1,530,411
Oct 8, 2025 11.15 11.43 11.13 11.27 11.27 1,574,809
Oct 7, 2025 11.50 11.70 11.05 11.09 11.09 2,098,224
Oct 6, 2025 11.34 11.71 11.25 11.56 11.56 2,113,439
Oct 3, 2025 11.13 11.41 11.00 11.34 11.34 2,110,877
Oct 2, 2025 11.10 11.19 10.95 11.05 11.05 1,779,203
Oct 1, 2025 11.45 11.50 11.00 11.05 11.05 3,951,904
Sep 30, 2025 12.08 12.29 11.61 11.63 11.63 1,915,219
Sep 29, 2025 11.64 12.00 11.41 11.85 11.85 2,574,535
Sep 26, 2025 11.05 11.38 10.96 11.30 11.30 1,904,945
Sep 25, 2025 11.28 11.34 10.95 11.12 11.12 1,829,601
Sep 24, 2025 11.51 11.72 11.11 11.24 11.24 2,698,028
Sep 23, 2025 11.51 12.07 11.35 11.44 11.44 3,241,229

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
CorMedix Inc. Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at CRMD, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation